A pack of 100 pen needles costs RUB 1,500 (USD 15 ... They switched to Fiasp, which worked well, but then they replaced it ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

Novo Nordisk (NVO) has reportedly launched its popular weight-loss drug Wegovy in China ahead of a rival drug by Eli Lilly ...

Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to ...

Discover the top disposable vapes in our comprehensive guide. Explore the best options for flavor, quality & convenience to ...

CGMs are prescribed to diabetics to monitor their blood sugar. They're now available and becoming wildly popular for over-the ...

Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...

In fact, more and more teens that meet certain weight and health criteria are going on GLP-1s after the FDA’s approval of Wegovy for children 12 and up in late 2022. The numbers of prescriptions of ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Weight loss drugs are incredibly sought-after, but they’re also often difficult to obtain due to limited insurance coverage ...